Clinical Trials Near Me

Medical studies near you are recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find the best clinical trials nearby.

LOCATION

Anywhere

CONDITION

Any

DRUG TYPE

Any

MORE FILTERS

More filters

Clear Filters

Filter Clinical Trials

Clear Filters

This study is evaluating whether a drug called desimelagen can be safely used for long-term treatment of depression.

This study is evaluating whether a drug called sotrovimab can help treat people with mild/moderate COVID-19.

Primary Objective: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former…

This study is evaluating whether a combination of two drugs may help treat ovarian cancer.

Vadadustat

Saint Clair Shores, MI

18+

All Sexes

Phase 3

Saint Clair Shores, MI

18+

All Sexes

This study is evaluating whether a drug may help treat anemia in individuals who are receiving hemodialysis.

This study is evaluating whether a combination of drugs may be more effective than a combination of drugs in treating multiple myeloma.

This study is evaluating whether a drug called ensifentrine may help treat COPD.

This study is evaluating whether a combination of two drugs may help prevent breast cancer from coming back.

This study is evaluating whether a combination of chemotherapy and immunotherapy may help treat anal cancer.

casirivimab+imdevimab combination therapy

Phase 1 To evaluate the safety and tolerability of REGN10933+REGN10987 compared to placebo To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral load of SARS-CoV-2 Phase 2 • To evaluate the virologic efficacy of REGN10933+REGN10987 compared to p…

This study is evaluating whether a drug may help prevent the development of a skin condition called Erythropoietic Protoporphyria (EPP) or X-linked Protop

Beclomethasone Dipropionate

This study is evaluating whether a drug may help improve lung function in individuals with chronic obstructive pulmonary disease.

Questionnaire Administration

This study is evaluating whether early treatment with a combination of two drugs may help patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Questionnaire Administration

This study is evaluating whether the addition of a drug to chemotherapy may help treat non-small cell lung cancer.

Mirvetuximab Soravtansine

This study is evaluating whether a drug may help treat ovarian cancer.

This study is evaluating whether a combination of two drugs may help treat lung cancer.

This study is evaluating whether a drug which blocks certain immune cells may help reduce the number of exacerbations in individuals with chronic obstructive pulmonary disease.

This study is evaluating whether a combination of drugs may help treat ovarian cancer.

This study is evaluating whether vitamin D3 may help treat colorectal cancer.

This study is evaluating whether an antibody may help treat lung cancer.

This study is evaluating whether a drug may help treat heart failure in patients with diabetes.

This study is evaluating whether a combination of two drugs may help patients with multiple myeloma.

Phase 3 study to evaluate the efficacy and safety of a benralizumab in patients with moderate to very severe COPD with a history of frequent COPD exacerbations and elevated peripheral blood eosinophils (≥300/μL). Eligible patients must have a history of ≥2 moderate and/or severe COPD exac…

Bupropion Hydrochloride Controlled-release

This study is evaluating whether bupropion may help reduce cancer related fatigue.

This study is evaluating whether lenalidomide and ixazomib work better than lenalidomide alone in treating patients with multiple myeloma.

This study is evaluating whether a combination of drugs may help treat patients with smoldering myeloma.

Bardoxolone methyl oral capsule

This study is evaluating whether a drug may help treat polycystic kidney disease.

This study is evaluating whether a combination of immunotherapy drugs and chemotherapy may help treat patients with Hodgkin lymphoma.

This study is evaluating whether dexamethasone can help reduce the side effects of everolimus.

Quality-of-Life Assessment

This study is evaluating whether a combination of chemotherapy and radiation therapy with or without an immunotherapy drug may help treat limited stage small cell lung cancer.

This study is evaluating whether a combination of chemotherapy and immunotherapy may be more effective than chemotherapy alone in treating non-small cell lung cancer.

This study is evaluating whether the addition of a drug to the treatment of patients with renal cell cancer may improve the effectiveness of the treatment.

Gemcitabine Hydrochloride

This study is evaluating whether a combination of chemotherapy drugs may help treat biliary tract cancer.

This study is evaluating whether a combination of drugs may help treat chronic lymphocytic leukemia.

This study is evaluating whether a combination of ibrutinib, obinutuzumab, and venetoclax is more effective than ibrutinib and obinutuzumab alone in treating patients with chronic lymphocy

Hypofractionated Radiation Therapy

This study is evaluating whether a type of radiation therapy may help prevent cancer from returning in patients who have had a mastectomy.

Cabozantinib S-malate

This study is evaluating whether a chemotherapy drug may help treat advanced neuroendocrine or carcinoid tumors.

Quality-of-Life Assessment

This study is evaluating whether a drug which blocks a checkpoint molecule may help treat bladder cancer.

This study is evaluating whether a type of immunotherapy may help treat anal cancer.

This study is evaluating whether a drug can be used to treat breast cancer.

Laboratory Biomarker Analysis

This study is evaluating whether chemotherapy may help treat germ cell tumors.

This study is evaluating whether a combination of chemotherapy, bevacizumab, and atezolizumab may help treat colorectal cancer.

This study is evaluating whether a type of immunotherapy may help treat triple-negative breast cancer.

This study is evaluating whether aspirin might prevent cancer recurrence in patients with breast cancer.

This study is evaluating whether a combination of chemotherapy and immunotherapy may be more effective than chemotherapy alone in treating colon cancer.

This study is evaluating whether a combination of chemotherapy and immunotherapy may help treat ovarian, fallopian tube, or primary peritoneal cancer.

This study is evaluating whether nivolumab is effective in treating patients with stage IB-IIIA non-small cell lung cancer.

This study is evaluating whether a combination of drugs and radiation therapy is more effective than radiation therapy alone in treating patients with solitary plasmacytoma of bone.

This study is evaluating whether high-dose interferon alfa-2b or ipilimumab is more effective than pembrolizumab in treating patients with stage III-IV melanoma.

Laboratory Biomarker Analysis

This study is evaluating whether a combination of chemotherapy drugs is more effective than chemotherapy alone in treating triple-negative breast cancer.

This study is evaluating whether a drug called veliparib can improve the survival of people with ovarian cancer.

This study is evaluating whether cisplatin or carboplatin is more effective than capecitabine in treating patients with residual basal-like triple-negative breast cancer. original:

This study is evaluating whether a combination of two immunotherapy drugs and a colony stimulating factor may help treat patients with advanced melanoma.

Quality-of-Life Assessment

This study is evaluating whether a combination of two immunotherapy drugs and a targeted therapy drug is more effective than a combination of two targeted therapy drugs in treating patients with stage III-IV melanoma

This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.

Erlotinib Hydrochloride

This study is evaluating whether erlotinib hydrochloride can improve survival in patients with non-small cell lung cancer.

This study is evaluating whether temozolomide and veliparib work better than temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.

This randomized phase III trial studies exemestane and entinostat to see how well they work compared to exemestane alone in treating patients with hormone receptor-positive breast cancer that has spread to nearby tissue or lymph nodes (locally advanced) or another place in the body (metast…

Quality-of-Life Assessment

This study is evaluating whether trametinib is more effective than standard therapy in treating patients with low-grade ovarian cancer or peritoneal cavity cancer that has come back, become worse, or spread to other parts of the body.

Questionnaire Administration

This study is evaluating whether paclitaxel, carboplatin, and metformin hydrochloride works better than paclitaxel, carboplatin, and placebo in treating patients with endometrial cancer.

This study is evaluating whether a combination of ibrutinib and rituximab is more effective than fludarabine phosphate, cyclophosphamide, and rituximab in treating patients with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.

This study is evaluating whether a combination of chemotherapy, radiation therapy, and hormone therapy is more effective than chemotherapy, radiation therapy, and hormone therapy alone in treating patients with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-

Quality-of-Life Assessment

This study is evaluating whether a combination of rituximab and bendamustine hydrochloride is more effective than ibrutinib alone in treating older patients with previously untreated chronic lymphocytic leukemia.

This study is evaluating whether a new drug combination is more effective than a standard drug combination in treating patients with multiple myeloma.

This study is evaluating whether a new drug called TAK-700 can improve survival in men with metastatic prostate cancer.

This study is evaluating whether hormone therapy is more effective when given with or without everolimus in treating patients with breast cancer.

Pazopanib Hydrochloride

This study is evaluating whether pazopanib hydrochloride is effective in treating patients with kidney cancer that has spread to other parts of the body and have no evidence of disease after surgery.

This study is evaluating whether a new treatment for rectal cancer is better than the standard treatment.

Eflornithine plus sulindac

This study is evaluating whether a combination of two drugs may help prevent the recurrence of colon cancer.

This study is evaluating whether chemotherapy with or without trastuzumab is more effective in treating women with invasive breast cancer.

Alfa Interferon

Washington, United States

Washington, United States

Any Age

All Sexes

This study is evaluating whether ipilimumab is more effective than interferon alfa-2b in treating patients with high-risk stage III-IV melanoma that has been removed by surgery.

This study is evaluating whether a drug called tamoxifen citrate, an aromatase inhibitor, or a drug called exemestane, an aromatase inhibitor, or a drug called letrozole, an aromatase inhibitor

This study is evaluating whether radiation therapy, paclitaxel, and carboplatin with or without trastuzumab work in treating patients with esophageal cancer.

This study is evaluating whether lenalidomide is more effective than observation alone in treating patients with asymptomatic high-risk smoldering multiple myeloma.

This study is evaluating whether paclitaxel is more effective when given with carboplatin and bevacizumab.

This study is evaluating whether a combination of drugs is more effective than a single drug in treating colon cancer.

This study is evaluating whether everolimus is effective in treating patients with kidney cancer.

External Beam Radiation Therapy

This study is evaluating whether radiation therapy with chemotherapy is more effective than radiation therapy alone in treating cervical cancer.

This study is evaluating whether a combination of chemotherapy drugs is more effective than a combination of chemotherapy drugs with a monoclonal antibody.

Doxorubicin Hydrochloride

This study is evaluating whether a combination of sorafenib and doxorubicin hydrochloride is more effective than sorafenib alone in treating patients with liver cancer.

3-Dimensional Conformal Radiation Therapy

This study is evaluating whether chemotherapy with or without erlotinib hydrochloride and/or radiation therapy is more effective than chemotherapy alone in treating patients with pancreatic cancer.

This study is evaluating whether paclitaxel and carboplatin are more effective than paclitaxel and ifosfamide in treating patients with fallopian tube, or peritoneal cavity cancer.

This study is evaluating whether chemotherapy with or without bevacizumab and/or cetuximab is more effective in treating patients with stage IV or non-small cell lung cancer that has returned after a period of improvement.

This study is evaluating whether chemotherapy and radiation therapy are more effective with or without chemotherapy and radiation therapy in treating patients with endometrial cancer.

This study is evaluating whether a combination of chemotherapy and immunotherapy is more effective than chemotherapy alone in treating patients with urinary tract cancer.

This study is evaluating whether radiation therapy is more effective than radiation therapy given together with androgen-deprivation therapy in treating patients with prostate cancer.

This study is evaluating whether pelvic radiation therapy is better than vaginal implant radiation therapy, paclitaxel, and carboplatin in treating patients with endometrial cancer.

This study is evaluating whether chemotherapy with or without bevacizumab is more effective in treating patients with stage IIIC or stage IV breast cancer.

Whole Breast Irradiation

This study is evaluating whether radiation therapy is more effective with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone lumpectomy.

Quality-of-Life Assessment

This study is evaluating whether changes in diet and physical activity can increase the length of survival without the return of cancer.

High Radiation Dose Therapy

This study is evaluating whether different radiation therapy regimens work better than others when given together with chemotherapy.

This study is evaluating whether melphalan and prednisone with thalidomide is more effective than melphalan and prednisone with lenalidomide in treating patients with newly diagnosed multiple myeloma.

This study is evaluating whether a combination of tamoxifen citrate and bevacizumab is more effective than tamoxifen citrate or bevacizumab alone in treating women with stage IIIB or stage IV breast cancer.

This study is evaluating whether chemotherapy with or without bevacizumab is more effective in treating patients with head and neck squamous cell carcinoma.

Recombinant Interferon Alfa-2b

This study is evaluating whether octreotide acetate and recombinant interferon alfa-2b are more effective than octreotide acetate and bevacizumab in treating patients with high-risk neuroendocrine tumors.

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.

Power

Clinical Trials Near Me

Medical studies near you are recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find the best clinical trials nearby.

What medical condition are you interested in?

Set your location & maximum travel distance